Correlation Between Procter Gamble and Clovis Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Procter Gamble and Clovis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procter Gamble and Clovis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Procter Gamble and Clovis Oncology, you can compare the effects of market volatilities on Procter Gamble and Clovis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procter Gamble with a short position of Clovis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procter Gamble and Clovis Oncology.

Diversification Opportunities for Procter Gamble and Clovis Oncology

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Procter and Clovis is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Procter Gamble and Clovis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clovis Oncology and Procter Gamble is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procter Gamble are associated (or correlated) with Clovis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clovis Oncology has no effect on the direction of Procter Gamble i.e., Procter Gamble and Clovis Oncology go up and down completely randomly.

Pair Corralation between Procter Gamble and Clovis Oncology

If you would invest  16,508  in Procter Gamble on September 3, 2024 and sell it today you would earn a total of  1,418  from holding Procter Gamble or generate 8.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy5.0%
ValuesDaily Returns

Procter Gamble  vs.  Clovis Oncology

 Performance 
       Timeline  
Procter Gamble 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Procter Gamble are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Procter Gamble is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.
Clovis Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clovis Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Clovis Oncology is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Procter Gamble and Clovis Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Procter Gamble and Clovis Oncology

The main advantage of trading using opposite Procter Gamble and Clovis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procter Gamble position performs unexpectedly, Clovis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clovis Oncology will offset losses from the drop in Clovis Oncology's long position.
The idea behind Procter Gamble and Clovis Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes